Is Wegovy or Mounjaro Better for Weight Loss?

Last reviewed: July 7, 2026

Last updated: July 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy (semaglutide) and Mounjaro (tirzepatide) have transformed weight loss treatment by targeting appetite-control hormones in the brain. Clinical trials show tirzepatide users lose 20-22% of body weight, while semaglutide users achieve 15-18% reductions. The choice between them depends on your genetics, metabolic profile, and response potential.

How Semaglutide and Tirzepatide Target Different Weight Loss Pathways

Semaglutide (the active ingredient in Wegovy) activates one hormone receptor called GLP-1, which slows stomach emptying and increases feelings of fullness. Tirzepatide (in Mounjaro) activates two receptors—GLP-1 and GIP—creating a dual-hormone effect. This dual mechanism explains why clinical data shows tirzepatide users typically lose more weight over the same timeframe.

Your genetic blueprint influences how effectively each medication works in your body. Some people respond better to single-pathway activation, while others show stronger results when both GLP-1 and GIP pathways are engaged. PlexusDx maps 14 metabolic pathways and analyzes key variants like GIPR rs1800437 and GLP1R rs6923761 to identify which approach aligns with your genetics.

Comparing Clinical Weight Loss Results Between the Two Medications

Published trials demonstrate measurable differences in efficacy. In the STEP trials, semaglutide at its highest dose produced an average weight loss of 15.3% of body weight over 68 weeks. In the SURPASS trials, tirzepatide at the same timepoint achieved 22.5% weight loss at the highest dose. Both medications beat placebo by significant margins, but tirzepatide's dual-receptor design produced stronger numerical outcomes.

Response times also differ between individuals. Some patients experience appetite suppression within days of starting semaglutide, while others may need weeks to notice meaningful changes. Tirzepatide users in trials showed dose-dependent improvements, meaning that as doses increased, weight loss continued to rise. Neither medication is universally 'better'—personal genetics and metabolic factors determine which delivers superior results for you.

Injectable vs Oral Delivery: Effectiveness and Convenience Trade-offs

Wegovy and Mounjaro are both injectable, dosed once weekly, making compliance straightforward for many patients. Oral versions of both medications exist but require daily dosing and show lower bioavailability (the amount of active drug your body actually absorbs). PlexusDx offers compounded semaglutide injection starting at $189/mo (or $149/mo on the 6-month plan) and compounded tirzepatide injection starting at $289/mo (or $249/mo on the 6-month plan), with all medications sourced from licensed 503A compounding pharmacies.

Injection-based therapy delivers consistent hormone receptor activation throughout the week, reducing the variability that can occur with daily oral dosing. For patients prioritizing weight loss efficacy, injectable formulations of either medication outperform their oral counterparts. PlexusDx also offers an oral tirzepatide option for patients who prefer daily pills, recognizing that adherence matters more than perfect pharmacokinetics if a patient won't stick with injections.

Cost, Access, and Personalization Without Insurance Requirements

Brand-name Wegovy and Mounjaro often require insurance approval or carry out-of-pocket costs exceeding $1,000 monthly. PlexusDx compounded tirzepatide injection begins at $289/mo (or $249/mo on the 6-month plan) across all 50 states with no insurance required, no membership fees, and HSA/FSA eligibility. Compounded semaglutide injection starts at $189/mo (or $149/mo on the 6-month plan), offering a lower entry point for patients beginning treatment.

Personalization amplifies treatment success beyond medication selection alone. PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month) to analyze your genetic variants in metabolic pathways controlling appetite, energy expenditure, and hormone sensitivity. This testing maps 49 distinct peptide functions across 150+ genetic insights, helping your provider adjust your protocol when initial results plateau or side effects emerge. Your dose may need to go up. Your price won't—PlexusDx maintains flat monthly pricing regardless of dose adjustments.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is tirzepatide actually more effective than semaglutide for weight loss?

Clinical trials show tirzepatide produces greater average weight loss (20-22% vs 15-18%), but individual response varies significantly. Some patients achieve excellent results with semaglutide alone, while others respond better to tirzepatide's dual-receptor mechanism. Genetic testing through PlexusDx can help identify which approach aligns with your metabolic profile.

Can I switch from Wegovy to Mounjaro if I'm not seeing results?

Yes, medication adjustments are part of precision weight loss therapy. If your body isn't responding adequately to semaglutide after 8-12 weeks at therapeutic doses, your provider may recommend switching to tirzepatide or adding complementary compounds. PlexusDx providers manage these transitions within your flat monthly pricing—dose escalation and medication changes don't increase your cost.

What's the difference between brand Mounjaro and compounded tirzepatide?

Both contain identical tirzepatide molecules and work through the same mechanisms. Compounded tirzepatide from licensed 503A pharmacies offers identical efficacy at a fraction of brand pricing, with PlexusDx compounded tirzepatide injection starting at $289/mo (or $249/mo on the 6-month plan). PlexusDx sources all compounded medications exclusively from licensed 503A facilities meeting rigorous quality standards.

Do side effects differ between Wegovy and Mounjaro?

Both cause similar GI side effects (nausea, vomiting, constipation) due to slowed stomach emptying, though tirzepatide users in trials reported slightly higher rates of nausea initially. Side effects typically diminish after 2-4 weeks as your body adapts. Dose escalation is gradual and personalized through PlexusDx to minimize discomfort while maximizing weight loss.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

The PlexusDx Precision Peptide Genetic Test analyzes variants like GIPR rs1800437 and GLP1R rs6923761 that influence appetite regulation and medication response. This test identifies your genetic predispositions across 14 metabolic pathways, giving your provider data-driven insights into whether a single-pathway (semaglutide) or dual-pathway (tirzepatide) approach is likely to produce superior results for your unique biology.

Related Reading

• Wegovy For Weight Loss 2
• Mounjaro For Weight Loss 2
• Wegovy Weight Loss Pills
• Weight Loss Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.